Profile
Christopher Jordan worked as Vice President-Regulatory Affairs at Endocyte, Inc. from 2018 to 2019.
He completed his graduate degree at George Washington University and his undergraduate degree at Purdue University.
Former positions of Christopher Jordan
| Companies | Position | End |
|---|---|---|
| ENDOCYTE, INC. | General Counsel | 2019-11-30 |
Training of Christopher Jordan
| Purdue University | Undergraduate Degree |
| George Washington University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Endocyte, Inc.
 Endocyte, Inc. Pharmaceuticals: MajorHealth Technology Endocyte, Inc. engages in the development of targeted therapies for the treatment of cancer and inflammatory diseases. It uses a proprietary technology to create novel small molecule drug conjugates and companion imaging diagnostics for personalized targeted therapies. Its small molecule drug conjugates are actively target receptors that are over-expressed on diseased cells. The company was founded by P. Ron Ellis and Philip S. Low on December 6, 1995 and is headquartered in West Lafayette, IN. | Health Technology |
- Stock Market
- Insiders
- Christopher Jordan
